Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Vascular endothelial growth factor gene 936 C/T polymorphism in breast cancer patients.

Literature DB >> 18188715

Vascular endothelial growth factor gene 936 C/T polymorphism in breast cancer patients.

Aydan Eroğlu¹, Ayşenur Oztürk, Ragip Cam, Nejat Akar.

Abstract

Entities: Disease Gene Mutation Species

Mesh：

Substances：

Year: 2007 PMID： 18188715 DOI： 10.1007/s12032-007-0046-4

Source DB: PubMed Journal: Med Oncol ISSN： 1357-0560 Impact factor: 3.064

× No keyword cloud information.

12 in total

1. Vascular endothelial growth factor 936 C/T polymorphism in cancer patients.

Authors: A Eroglu; S Gulec; C Kurtman; R Cam; N Akar
Journal: Ann Oncol Date: 2006-04-06 Impact factor: 32.976

2. Population-based case-control study of VEGF gene polymorphisms and breast cancer risk among Chinese women.

Authors: Nobuhiko Kataoka; Qiuyin Cai; Wanqing Wen; Xiao-Ou Shu; Fan Jin; Yu-Tang Gao; Wei Zheng
Journal: Cancer Epidemiol Biomarkers Prev Date: 2006-06 Impact factor: 4.254

3. Vascular endothelial growth factor gene polymorphisms and risk of primary lung cancer.

Authors: Su Jeong Lee; Sin Yeob Lee; Hyo-Sung Jeon; Sun Ha Park; Jin Sung Jang; Ga Young Lee; Ji Woong Son; Chang Ho Kim; Won Kee Lee; Sin Kam; Rang Woon Park; Tae-In Park; Young Mo Kang; In-San Kim; Tae Hoon Jung; Jae Yong Park
Journal: Cancer Epidemiol Biomarkers Prev Date: 2005-03 Impact factor: 4.254

4. A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels.

Authors: W Renner; S Kotschan; C Hoffmann; B Obermayer-Pietsch; E Pilger
Journal: J Vasc Res Date: 2000 Nov-Dec Impact factor: 1.934

Review 5. Clinical implications of circulating angiogenic factors in cancer patients.

Authors: R T Poon; S T Fan; J Wong
Journal: J Clin Oncol Date: 2001-02-15 Impact factor: 44.544

6. Association of VEGF genetic polymorphisms with prostate carcinoma risk and clinical outcome.

Authors: Sana Sfar; Elham Hassen; Hamadi Saad; Faouzi Mosbah; Lotfi Chouchane
Journal: Cytokine Date: 2006-09-05 Impact factor: 3.861

7. Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma.

Authors: G Gasparini; M Toi; M Gion; P Verderio; R Dittadi; M Hanatani; I Matsubara; O Vinante; E Bonoldi; P Boracchi; C Gatti; H Suzuki; T Tominaga
Journal: J Natl Cancer Inst Date: 1997-01-15 Impact factor: 13.506

8. Vascular endothelial growth factor polymorphisms in relation to breast cancer development and prognosis.

Authors: Qianren Jin; Kari Hemminki; Kerstin Enquist; Per Lenner; Ewa Grzybowska; Rüdiger Klaes; Roger Henriksson; Bowang Chen; Jolanta Pamula; Wioletta Pekala; Helena Zientek; Jadwiga Rogozinska-Szczepka; Beata Utracka-Hutka; Göran Hallmans; Asta Försti
Journal: Clin Cancer Res Date: 2005-05-15 Impact factor: 12.531

9. Polymorphisms in the vascular endothelial growth factor gene and breast cancer in the Cancer Prevention Study II cohort.

Authors: Eric J Jacobs; Heather Spencer Feigelson; Elizabeth B Bain; Kerri A Brady; Carmen Rodriguez; Victoria L Stevens; Alpa V Patel; Michael J Thun; Eugenia E Calle
Journal: Breast Cancer Res Date: 2006-04-13 Impact factor: 6.466

10. Assignment of the vascular endothelial growth factor gene to human chromosome 6p21.3.

Authors: V Vincenti; C Cassano; M Rocchi; G Persico
Journal: Circulation Date: 1996-04-15 Impact factor: 29.690

11 in total

1. Polymorphisms in the 5'- and 3'-untranslated region of the VEGF gene and sporadic breast cancer risk and clinicopathologic characteristics.

Authors: Cristiane Oliveira; Gustavo J Lourenço; Priscilla M R Silva; Cassio Cardoso-Filho; Maira H C Favarelli; Neiva S L Gonçales; Maria S C Gurgel; Carmen S P Lima
Journal: Tumour Biol Date: 2010-10-28

2. Genetic variation in VEGF family genes and breast cancer risk: a report from the Shanghai Breast Cancer Genetics Study.

Authors: Alicia Beeghly-Fadiel; Xiao-Ou Shu; Wei Lu; Jirong Long; Qiuyin Cai; Yong-Bing Xiang; Ying Zheng; Zhongming Zhao; Kai Gu; Yu-Tang Gao; Wei Zheng
Journal: Cancer Epidemiol Biomarkers Prev Date: 2010-11-30 Impact factor: 4.254

3. Association between vascular endothelial growth factor +936C/T polymorphism and breast cancer risk: a meta-analysis of 18 case-control studies.

Authors: Danhui Huang; Jianhua Wu; Zhenya Sun; Senlin Huang; Yuzhao Zhang; Lingling Wang; Tao Zeng
Journal: Int J Mol Epidemiol Genet Date: 2016-09-30

4. The single nucleotide polymorphism +936 C/T VEGF is associated with human epidermal growth factor receptor 2 expression in Moroccan breast cancer women.

Authors: Jalila Rahoui; Yassir Sbitti; Nadia Touil; Abdelilah Laraqui; Azeddine Ibrahimi; Brahim Rhrab; Abderrahman Al Bouzidi; Driss Moussaoui Rahali; Mohamed Dehayni; Mohamed Ichou; Fatima Zaoui; Saad Mrani
Journal: Med Oncol Date: 2014-11-22 Impact factor: 3.064

5. Prognostic evaluation of VEGFA genotypes and haplotypes in a cohort of Brazilian women with non metastatic breast cancer.

Authors: Hayra de Andrade Vieira-Monteiro; Daniely Regina Freitas-Alves; Marcelo Sobral-Leite; João Marcos de Azevedo Delou; Sheyla Maria Torres Goulart-Citrangulo; Camila Telles do Nascimento; Thales Nascimento E Castro; Sérgio Koifman; Jamila Alessandra Perini; Rosane Vianna-Jorge
Journal: Cancer Biol Ther Date: 2016-06-02 Impact factor: 4.742

6. Polymorphism of VEGF-460C/T associated with the risk and clinical characteristics of lung cancer in Chinese population.

Authors: Shi-Fang Sun; Da-Bing Huang; Chao Cao; Zai-Chun Deng
Journal: Med Oncol Date: 2013-01-04 Impact factor: 3.064

Review 7. The role of vascular endothelial growth factor SNPs as predictive and prognostic markers for major solid tumors.

Authors: Lokesh Jain; Craig A Vargo; Romano Danesi; Tristan M Sissung; Douglas K Price; David Venzon; Jürgen Venitz; William D Figg
Journal: Mol Cancer Ther Date: 2009-09-15 Impact factor: 6.261